NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-160379 | Service
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Next-Generation Sequencing (NGS) in Cancer Research Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET
7.1 GLOBAL NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING (NGS) IN CANCER RESEARCH MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Illumina Incorporated
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 PerkinElmer
16.3 Pacific Biosciences
16.4 Knome lnc
16.5 Macrogen Ilnc
16.6 Life Sciences (Roche)
16.7 Agilent Technologies lnc
16.8 Pacific Biosciences
16.9 Qiagen NV
16.10 Next-Generation Sequencing (NGS)
16.11 Partek Inc
16.12 Biomatters Ltd
16.13 BCl(Beijing Cenomies lnstitute)
16.14 DNASTAR Inc
16.15 Thermo Fischer Scientific
16.16 GATC Biotech AG
16.17 Cenomatix Software CmbH
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types CoveredIon Semiconductor Sequencing
Others
Single-molecule Real-time Sequencing
Nanopore Sequencing
Sequencing by Synthesis
Major Downstream Industry Covered
Academic Institutes & Research Centers
Others
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Companies
Illumina Incorporated
PerkinElmer
Pacific Biosciences
Knome lnc
Macrogen Ilnc
Life Sciences (Roche)
Agilent Technologies lnc
Pacific Biosciences
Qiagen NV
Next-Generation Sequencing (NGS)
Partek Inc
Biomatters Ltd
BCl(Beijing Cenomies lnstitute)
DNASTAR Inc
Thermo Fischer Scientific
GATC Biotech AG
Cenomatix Software CmbH
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.